Recent Research Analysts’ Ratings Updates for Surgery Partners (SGRY)

Surgery Partners (NASDAQ: SGRY) has recently received a number of price target changes and ratings updates:

• 11/14/2023 – Surgery Partners was upgraded by analysts at TD Cowen from a “market perform” rating to an “outperform” rating. They now have a $35.00 price target on the stock, down previously from $39.00.
• 11/10/2023 – Surgery Partners was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating.
• 11/2/2023 – Surgery Partners was downgraded by analysts at TheStreet from a “c-” rating to a “d+” rating.
• 11/1/2023 – Surgery Partners was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating.
• 10/12/2023 – Surgery Partners had its “buy” rating reaffirmed by analysts at Benchmark Co.. They now have a $50.00 price target on the stock.
• 10/5/2023 – Surgery Partners is now covered by analysts at StockNews.com. They set a “hold” rating on the stock.
• 9/23/2023 – Surgery Partners was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating.

Surgery Partners Trading Down 0.4 %

NASDAQ:SGRY opened at $32.11 on Tuesday. Surgery Partners, Inc. has a one year low of $22.05 and a one year high of $45.79. The company has a market cap of $4.06 billion, a PE ratio of -100.34 and a beta of 2.78. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.75 and a quick ratio of 1.61. The firm has a 50-day moving average of $27.38 and a 200-day moving average of $34.31.

Insiders Place Their Bets

In other news, insider Harrison R. Bane sold 3,835 shares of the firm’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $35.98, for a total value of $137,983.30. Following the transaction, the insider now owns 46,709 shares in the company, valued at $1,680,589.82. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 2.60% of the company’s stock.

Institutional Trading of Surgery Partners

Institutional investors and hedge funds have recently made changes to their positions in the company. Raymond James & Associates boosted its holdings in Surgery Partners by 7.9% during the first quarter. Raymond James & Associates now owns 37,700 shares of the company’s stock worth $2,075,000 after purchasing an additional 2,758 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in shares of Surgery Partners by 0.7% in the first quarter. Bank of New York Mellon Corp now owns 137,662 shares of the company’s stock valued at $7,578,000 after acquiring an additional 900 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of Surgery Partners by 34.7% during the first quarter. PNC Financial Services Group Inc. now owns 1,195 shares of the company’s stock valued at $66,000 after acquiring an additional 308 shares during the last quarter. MetLife Investment Management LLC increased its position in shares of Surgery Partners by 54.2% during the 1st quarter. MetLife Investment Management LLC now owns 18,141 shares of the company’s stock valued at $999,000 after purchasing an additional 6,374 shares during the last quarter. Finally, Panagora Asset Management Inc. purchased a new stake in Surgery Partners during the first quarter worth about $851,000.

Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through two segments, Surgical Facility Services and Ancillary Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.